News >

Evaluating Surgery and Angiogenesis Inhibition in Recurrent Ovarian Cancer

Caroline Seymour
Published: Sunday, Jul 21, 2019

Angeles Alvarez Secord, MD, MHSc

Angeles Alvarez Secord, MD, MHSc

Although chemotherapy remains the bedrock of treatment for patients with recurrent ovarian cancer, the field is moving beyond paradigms of platinum sensitivity and resistance and relying on a multiplex classification system to better design personalized treatment strategies.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication